UBS Group’s Ventyx Biosciences VTYX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $786K | Buy |
367,509
+57,897
| +19% | +$124K | ﹤0.01% | 4523 |
|
|
2025
Q1 | $356K | Sell |
309,612
-3,472,971
| -92% | -$3.99M | ﹤0.01% | 4911 |
|
|
2024
Q4 | $8.28M | Buy |
3,782,583
+2,585,197
| +216% | +$5.66M | ﹤0.01% | 2525 |
|
|
2024
Q3 | $2.61M | Buy |
1,197,386
+1,175,766
| +5,438% | +$2.56M | ﹤0.01% | 2826 |
|
|
2024
Q2 | $49.9K | Sell |
21,620
-37,899
| -64% | -$87.5K | ﹤0.01% | 5547 |
|
|
2024
Q1 | $327K | Buy |
+59,519
| New | +$327K | ﹤0.01% | 4385 |
|
|
2023
Q4 | – | Sell |
-193
| Closed | -$6.7K | – | 8594 |
|
|
2023
Q3 | $6.7K | Sell |
193
-42,437
| -100% | -$1.47M | ﹤0.01% | 6140 |
|
|
2023
Q2 | $1.4M | Buy |
42,630
+42,346
| +14,911% | +$1.39M | ﹤0.01% | 3007 |
|
|
2023
Q1 | $9.52K | Sell |
284
-945
| -77% | -$31.7K | ﹤0.01% | 6550 |
|
|
2022
Q4 | $40.3K | Buy |
+1,229
| New | +$40.3K | ﹤0.01% | 5810 |
|
|
2022
Q3 | – | Sell |
-2,052
| Closed | -$25K | – | 9733 |
|
|
2022
Q2 | $25K | Sell |
2,052
-816
| -28% | -$9.94K | ﹤0.01% | 5586 |
|
|
2022
Q1 | $39K | Sell |
2,868
-932
| -25% | -$12.7K | ﹤0.01% | 5714 |
|
|
2021
Q4 | $76K | Buy |
+3,800
| New | +$76K | ﹤0.01% | 5459 |
|